Mineralys Therapeutics, Inc. MLYS Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Mineralys Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s book value per share?
- Mineralys Therapeutics, Inc. (MLYS) reported book value per share of $7.70 in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s book value per share changed year-over-year?
- Mineralys Therapeutics, Inc.'s book value per share increased by 19.9% year-over-year, from $6.42 to $7.70.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s book value per share?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s book value per share has grown at a -1.9% compound annual growth rate (CAGR), from -$10.12 to $9.56.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.